Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206633788> ?p ?o ?g. }
- W4206633788 endingPage "103579" @default.
- W4206633788 startingPage "103579" @default.
- W4206633788 abstract "Immune checkpoint inhibitors (ICIs) have led to a significant change in the treatment of urological tumors where several agents are currently approved. Yet, most patients discontinue treatment due to disease progression or after the onset of severe immune-related adverse events (IRAEs). Following promising results in melanoma patients, retreatment with an ICI is receiving increasing attention as an attractive option for selected patients. We performed a literature review focusing on the feasibility, safety, timing and activity of ICI rechallenge in genitourinary cancers where very little information is available. We classified the different ICI retreatment strategies into three main clinical scenarios: retreatment after terminating a prior course of ICI while still on response; retreatment after interruption due to IRAEs; retreatment after progression while on ICI therapy. The pros and cons of these options in the field of urological tumors are then discussed, and critical suggestions proffered for the design of future clinical trials." @default.
- W4206633788 created "2022-01-25" @default.
- W4206633788 creator A5004473647 @default.
- W4206633788 creator A5016079887 @default.
- W4206633788 creator A5018516577 @default.
- W4206633788 creator A5027196294 @default.
- W4206633788 creator A5034356923 @default.
- W4206633788 creator A5034433849 @default.
- W4206633788 creator A5036928489 @default.
- W4206633788 creator A5059198507 @default.
- W4206633788 creator A5082704939 @default.
- W4206633788 date "2022-02-01" @default.
- W4206633788 modified "2023-09-28" @default.
- W4206633788 title "Immune checkpoint inhibitors rechallenge in urological tumors: An extensive review of the literature" @default.
- W4206633788 cites W1971554504 @default.
- W4206633788 cites W1979811833 @default.
- W4206633788 cites W2010121426 @default.
- W4206633788 cites W2125112000 @default.
- W4206633788 cites W2130826590 @default.
- W4206633788 cites W2143488876 @default.
- W4206633788 cites W2156261087 @default.
- W4206633788 cites W2265285917 @default.
- W4206633788 cites W2386935098 @default.
- W4206633788 cites W2412250098 @default.
- W4206633788 cites W2531934133 @default.
- W4206633788 cites W2562305489 @default.
- W4206633788 cites W2587048937 @default.
- W4206633788 cites W2592144107 @default.
- W4206633788 cites W2606976048 @default.
- W4206633788 cites W2616677257 @default.
- W4206633788 cites W2726861941 @default.
- W4206633788 cites W2744302105 @default.
- W4206633788 cites W2748657765 @default.
- W4206633788 cites W2752793362 @default.
- W4206633788 cites W2760893760 @default.
- W4206633788 cites W2766729634 @default.
- W4206633788 cites W2779503684 @default.
- W4206633788 cites W2782007611 @default.
- W4206633788 cites W2786816161 @default.
- W4206633788 cites W2790568323 @default.
- W4206633788 cites W2809994753 @default.
- W4206633788 cites W2810784008 @default.
- W4206633788 cites W2831487285 @default.
- W4206633788 cites W2838357484 @default.
- W4206633788 cites W2885738414 @default.
- W4206633788 cites W2886349478 @default.
- W4206633788 cites W2889311568 @default.
- W4206633788 cites W2889605632 @default.
- W4206633788 cites W2890827908 @default.
- W4206633788 cites W2891944247 @default.
- W4206633788 cites W2898545983 @default.
- W4206633788 cites W2908503672 @default.
- W4206633788 cites W2909887958 @default.
- W4206633788 cites W2913745075 @default.
- W4206633788 cites W2921611058 @default.
- W4206633788 cites W2933124473 @default.
- W4206633788 cites W2945590213 @default.
- W4206633788 cites W2945674342 @default.
- W4206633788 cites W2946620483 @default.
- W4206633788 cites W2948397884 @default.
- W4206633788 cites W2949375297 @default.
- W4206633788 cites W2956028371 @default.
- W4206633788 cites W2963342775 @default.
- W4206633788 cites W2970398376 @default.
- W4206633788 cites W2970952192 @default.
- W4206633788 cites W2978412906 @default.
- W4206633788 cites W2978886519 @default.
- W4206633788 cites W2983048748 @default.
- W4206633788 cites W2988124258 @default.
- W4206633788 cites W2997049373 @default.
- W4206633788 cites W2998298043 @default.
- W4206633788 cites W2998511916 @default.
- W4206633788 cites W2998816180 @default.
- W4206633788 cites W2999032994 @default.
- W4206633788 cites W2999042597 @default.
- W4206633788 cites W3000344266 @default.
- W4206633788 cites W3005088442 @default.
- W4206633788 cites W3007099934 @default.
- W4206633788 cites W3007321116 @default.
- W4206633788 cites W3008168317 @default.
- W4206633788 cites W3009025691 @default.
- W4206633788 cites W3024551702 @default.
- W4206633788 cites W3028977302 @default.
- W4206633788 cites W3029478055 @default.
- W4206633788 cites W3029582640 @default.
- W4206633788 cites W3029840434 @default.
- W4206633788 cites W3031933721 @default.
- W4206633788 cites W3046552417 @default.
- W4206633788 cites W3087464965 @default.
- W4206633788 cites W3087466624 @default.
- W4206633788 cites W3122530988 @default.
- W4206633788 cites W3122946735 @default.
- W4206633788 cites W3131063362 @default.
- W4206633788 cites W3134949580 @default.
- W4206633788 cites W4256631179 @default.
- W4206633788 doi "https://doi.org/10.1016/j.critrevonc.2022.103579" @default.
- W4206633788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35007699" @default.
- W4206633788 hasPublicationYear "2022" @default.